Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

BACKGROUND: Haematological malignancies and their treatments are likely to affect SARS-CoV-2 vaccine efficacy. We aimed to evaluate serological response to BNT162b2 vaccine in patients with haematological malignancies by type of treatment. METHODS: Our national prospective cohort study was done in L...

Descripción completa

Detalles Bibliográficos
Autores principales: Maneikis, Kazimieras, Šablauskas, Karolis, Ringelevičiūtė, Ugnė, Vaitekėnaitė, Vilmantė, Čekauskienė, Rita, Kryžauskaitė, Lina, Naumovas, Daniel, Banys, Valdas, Pečeliūnas, Valdas, Beinortas, Tumas, Griškevičius, Laimonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253543/
https://www.ncbi.nlm.nih.gov/pubmed/34224668
http://dx.doi.org/10.1016/S2352-3026(21)00169-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253543/
https://www.ncbi.nlm.nih.gov/pubmed/34224668
http://dx.doi.org/10.1016/S2352-3026(21)00169-1

Ejemplares similares